Community
Forum | Search | Radio |
Journal
Club CME | About
Medjournal.Com |
Bookmark
This Page | Recommend
Us! | Contact |
Press Releases |
Privacy Statement |
translate this page
$i=0;
$url[$i]="http://www.acc.org";
$name[$i]="Amer Coll Cardiol";$i++;
#
$url[$i]="http://www.ajcn.org/current.shtml";
$name[$i]="Amer J Clin Nutrition";$i++;
#
$url[$i]="http://www.ama-assn.org/public/journals/amnews";
$name[$i]="Amer Med News";$i++;
#
$url[$i]="http://www.medicinedirect.com/journal/journal/current?sdid=5195";
$name[$i]="American J Medicine";$i++;
#
$url[$i]="http://www.annfammed.org/instructions.html";
$name[$i]="Ann Fam Med";$i++;
#
$url[$i]="http://www.annals.org/";
$name[$i]="Ann Internal Med";$i++;
#
$url[$i]="http://news.bbc.co.uk/hi/english/health/default.stm";
$name[$i]="BBC Health";$i++;
#
$url[$i]="http://bmj.com/current.shtml";
$name[$i]="BMJ";$i++;
#
$url[$i]="http://caonline.amcancersoc.org/";
$name[$i]="CA Cancer J";$i++;
#
$url[$i]="http://www.cmaj.ca";
$name[$i]="Canadian Med Assn J";$i++;
#
$url[$i]="http://www.acc.org/education/online/nuclear_month/index.htm";
$name[$i]="Case of the Month";$i++;
#
$url[$i]="http://circ.ahajournals.org/current.shtml";
$name[$i]="Circulation";$i++;
#
$url[$i]="http://www.drudgereport.com";
$name[$i]="Drudge";$i++;
#
$url[$i]="http://emj.bmjjournals.com/current.shtml";
$name[$i]="Emergency Med J";$i++;
#
$url[$i]="http://www.epidem.com";
$name[$i]="Epidemiology";$i++;
#
$url[$i]="http://fampra.oupjournals.org/current.shtml";
$name[$i]="Family Practice";$i++;
#
$url[$i]="http://news.google.com/news/gnhealthleftnav.html";
$name[$i]="Google";$i++;
#
$url[$i]="http://ip.bmjjournals.com/current.shtml";
$name[$i]="Injury Prevention";$i++;
#
$url[$i]="http://jncicancerspectrum.oupjournals.org/jnci/current.shtml";
$name[$i]="J Natl Cancer Inst";$i++;
#
$url[$i]="http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=home&id=nc";
$name[$i]="J Nuclear Cardiol";$i++;
#
$url[$i]="http://jnm.snmjournals.org/";
$name[$i]="J Nuclear Med";$i++;
#
$url[$i]="http://jama.ama-assn.org/issues/current/toc.html";
$name[$i]="JAMA";$i++;
#
$url[$i]="http://www.kaisernetwork.org/health_cast/hcast_index.cfm";
$name[$i]="Kaiser Network";$i++;
#
$url[$i]="http://www.thelancet.com/journal/current";
$name[$i]="Lancet";$i++;
#
$url[$i]="http://www.pubmed.com";
$name[$i]="Medline";$i++;
#
$url[$i]="http://www.cdc.gov/mmwr/";
$name[$i]="Morbidity & Mortality";$i++;
#
$url[$i]="http://content.nejm.org";
$name[$i]="NEJM";$i++;
#
$url[$i]="http://www.guideline.gov/VIEWS/summary.asp?guideline=2320&summary_type=brief_summary&view=brief_summary&sSearch_string=";
$name[$i]="Practice Guidelines";$i++;
#
$url[$i]="http://www.nature.com/nsu/categories/healthandmedicine.html";
$name[$i]="Nature";$i++;
#
$url[$i]="http://www.newsmax.com/hottopics/Health_Issues.shtml";
$name[$i]="NewsMax";$i++;
#
$url[$i]="http://www.patientcareonline.com";
$name[$i]="Patient Care";$i++;
#
$url[$i]="http://www.preventiveservices.ahrq.gov";
$name[$i]="Preventive Services";$i++;
#
$url[$i]="http://www.pnas.org";
$name[$i]="Proc Natl Acad Sci";$i++;
#
$url[$i]="http://reuters.com/newsChannel.jhtml?type=healthNews";
$name[$i]="Reuters";$i++;
#
$url[$i]="http://www.sciam.com/";
$name[$i]="Scientific American";$i++;
#
$timex=time();
srand($timex);
for($x=0;$x<$i;$x++){
echo "* $name[$x] \n";
}
$whichone=rand(0,$i);
echo " ** Random Link ** \n";
?>
|
Thursday, June 20, 2002
Syndrome X Chest Pain Associated With Subendocardial Hypoperfusion
$countera++;
$newsitem[$countera]="$BlogItemSubject";
$newslink[$countera]="http://www.medjournal.com/blog/archives/2002_06_01_heartarchive.php#85185508";
?> This MRI study of 20 patients with syndrome X (typical angina, abnormal exercise ECG test results, and normal coronary angiogram) and 10 control patients, subendocardial hypoperfusion was demonstrated after adenosine stress. This suggests that the chest pain in syndrome X is due to myocardial ischemia. [ article ] posted at 8:31 AM
by Tom Heston, MD
Monday, June 17, 2002
Disagreement Over the Meaning of HOPE: the Use of Ramipril to Prevent Cardiovascular Events
$countera++;
$newsitem[$countera]="$BlogItemSubject";
$newslink[$countera]="http://www.medjournal.com/blog/archives/2002_06_01_heartarchive.php#85177310";
?> Letters to the editor published in Lancet raise interesting points about the HOPE trial, which showed a significant benefit of adding ramipril to other blood pressure medications. The main authors of the HOPE trial respond convincingly. Comment: this is interesting reading. I tend to side with the authors of the HOPE trial, and believe that ramipril is a promising medication in terms of cardiovascular disease treatment and prevention. [ article ] posted at 11:58 AM
by Tom Heston, MD
Friday, June 14, 2002
Dual Chamber Pacing Best for Sinus Node Dysfunction
$countera++;
$newsitem[$countera]="$BlogItemSubject";
$newslink[$countera]="http://www.medjournal.com/blog/archives/2002_06_01_heartarchive.php#85171342";
?> This study of 2010 patients with sinus node dysfunction found that dual chamber pacing (atrioventricular) was better than single chamber (ventricular only) pacing. There was no difference between the two groups in terms of mortality or stroke-free survival, however, those with dual chamber pacemakers had fewer signs and symptoms of heart failure, and an improved quality of life. [ article ] posted at 3:07 PM
by Tom Heston, MD
Raloxifene Shown to Reduce Strokes and Coronary Events
$countera++;
$newsitem[$countera]="$BlogItemSubject";
$newslink[$countera]="http://www.medjournal.com/blog/archives/2002_06_01_heartarchive.php#85169459";
?> Research presented at the annual meeting of the American College of Cardiology reported that among the 1035 participants in the MORE trial, those who took 60 mg/day of raloxifene (an alternative to hormone replacement therapy) had a 40% reduction in coronary events compared with those taking a placebo. The reduction in strokes was 62%. Comment: this selective estrogen receptor modulator is very promising, and likely will be the preferred post-menopausal agent, replacing estrogen. [ Family Practice News 15 May 2002;32(10):1 ] posted at 2:32 PM
by Tom Heston, MD
Thursday, June 13, 2002
Therapeutic Angiogenesis Shows Potential for Treating Vascular Disease
$countera++;
$newsitem[$countera]="$BlogItemSubject";
$newslink[$countera]="http://www.medjournal.com/blog/archives/2002_06_01_heartarchive.php#85169563";
?> This study of 190 patients with intermittent claudication in their legs showed a good response to the intra-arterial infusion of recombinant fibroblast growth factor-2. Comment: this growth factor may eventually help cardiac patients grow collateral vessels, decreasing the need for repeat stenting or bypass surgery. [ article ] posted at 11:53 PM
by Tom Heston, MD
click
here for more medical news and commentary...
 We
subscribe to the HONcode
code of conduct for medical and health websites
The
information contained on all web pages maintained by Medjournal.Com is strictly
editorial. It constitutes medical opinion, NOT ADVICE. Use common sense by consulting
with your doctor before making any lifestyle changes or other medical decisions
based on the content of these web pages. Medjournal.Com and the Internet Medical
Journal shall not be held liable for any errors in content, advertising, or for
any actions taken in reliance thereon.
| | |
©
1997-2002 by Medjournal.Com, Inc. and The Internet Medical Journal ISSN 1093-7935.
All international rights reserved. This copyright applies to the entire domain
medjournal.com
We use with permission and recommend
Spiderweb Links,
LinksToYou,
Blogger Pro,
Medjournal.com,
TradeMyPage.com,
StartPageAds.com,
Heston.com,
StayAtHomeMom.com,
SilverValley.Org,
ACOMS.org,
Medjournal.org,
Shaklee Distributor,
HitsOverload.com.
Click Here to view our privacy
statement.
The Internet Medical Journal
Dedicated
to Your Good Health!
|